Philip Warren Majerus (10 July 1936 – 8 June 2016) was an American biochemist who confirmed the cardiovascular benefits of aspirin.
As a child, he had no interest in any school subject other than science, and he seemed to thrive once one of his schoolteachers set up a chemistry laboratory where Majerus could perform hands-on experiments.
[2] Majerus was a talented tennis player, which earned him an athletic scholarship to the University of Notre Dame, where he completed an undergraduate degree in 1958.
[3] After completing a residency at Massachusetts General Hospital, Majerus worked for the National Heart Institute, conducting research on fatty acid biosynthesis in E. coli in the laboratory of P. Roy Vagelos.
[5] Majerus studied the role of platelets in the clotting process, and he proved that low-dose aspirin therapy could reduce the incidence of heart attack and stroke.